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INTRODUCTION
Antibiotics, the miracle drugs in human medicine, saved millions of lives and eased patients' suffering from bacterial infections. However, bacteria can evolve rapidly and acquire resistance to antibiotic when continually exposed to antibiotics. In 2009, 7.4 million pounds of antibiotics were sold to treat bacterial infections in humans (US-GAO 2011) and approximately four times that amount (28.8 million pounds) were used for food animal production in the United States (FDA 2010) . The intensive use of antibiotics increased rapidly the prevalence of drug-resistant human pathogens. For example, quinoloneresistant Pseudomonas aeruginosa isolated from intensive care units in the United States increased from 19% in 1990-1993 to 34% in 2000 , which correlated with a 2.5-fold increase in the use of quinolones during the same period (Neuhauser et al. 2003) . Moreover, some Gram-negative human pathogens, including P. aeruginosa, Acinetobacter spp. and members of the Enterobacteriaceae, are becoming resistant to almost all current antibiotics (CDC 2013) . Antibiotic-resistant pathogens have become one of the most serious public health threats. It is estimated that at least 23 000 people die each year due to the antibiotic-resistant infections in the United States (CDC 2013) . Therefore, there is a perpetual need for novel, safe and effective antimicrobials to fight the emerging antibiotic-resistant pathogens.
Bacteria remain an important source of novel antibiotics that have new scaffolds and mechanisms of action (Clardy, Fischbach and Walsh 2006) . Paenibacillus spp., the conventional biocontrol agents for crop protection, produce a variety of antimicrobial agents. Examples of the bioactive compound categories from Paenibacillus include lantibiotics (He et al. 2008; Lohans et al. 2012) and lipopeptides (Li et al. 2007; Choi et al. 2009; Guo et al. 2012 ). In the current study, a new Paenibacillus strain, isolated from dry mushrooms, produced a mixture of potent antimicrobial agents against both Gram-negative and Gram-positive bacteria. Mass spectrometry analysis of the mixture revealed two previously known antimicrobial cyclic lipopeptides, a new cyclic lipopeptide and three newly-revealed linear counterparts. This research was done to determine the contribution of the linear members of this family to its broad antimicrobial activity; therefore, linear analogs of these lipopeptides were synthesized and tested. The study is based on the hypothesis that cyclization is not essential for the activity of the lipopeptides in this family.
MATERIALS AND METHODS

Bacterial strains and media
The producer strain, Paenibacillus sp. OSY-N, was isolated from dry mushrooms that were collected from a local grocery store in Columbus, Ohio, in 2013. A procedure described by Guo et al. (2012) was followed for strain isolation from the food using two indicator microorganisms: Listeria innocua ATCC 33090 and Escherichia coli K-12. The producer strain was cultured in tryptic soy broth (TSB; Becton Dickinson, Sparks, MD) or tryptic soy agar (TSA) at 37
• C. Other bacterial strains used in the antimicrobial activity assays were obtained from the Food Microbial Safety Laboratory at The Ohio State University. These microorganisms were grown in TSB at 37 • C.
Isolation and purification of antimicrobial agents
Colonies of OSY-N were collected from TSA and cells were suspended in TSB. The cell suspension was used as an inoculum for antimicrobial production. Aliquots (100 μl) of cell suspension were spread plated onto TSA plates which were incubated at 37
• C for 72 h. After incubation, bacterial cells and associated metabolites were harvested by scraping the colonies from 300 agar plates. Antimicrobial agents produced by OSY-N were extracted using isopropanol with agitation at 200 rpm at 30 • C for 3 h. After extraction, bacterial cells were removed by centrifugation at 7710 × g for 10 min. The resultant supernatant, which contained the antimicrobial agents, was air-dried in a chemical hood. The dry crude extract was dissolved in distilled water and filter-sterilized using a 0.45-μm low protein-binding membrane filter (Millipore Corp., Bedford, MA). The cell-free crude extract was first purified using C 18 cartridges (Sep-Pak C 18 ; Waters Cooperation, Milford, MA). The active fraction, eluted by 50% acetonitrile from cartridges, was air-dried and further purified by high-performance liquid chromatography (HPLC). HPLC purification was achieved using a reverse-phase column with 5 μm particle size (250 × 4.6 mm; biobasic, Thermo Electron Corp., Bellefonte, PA). The mobile phase consisted of (A) HPLC grade water and (B) a mixture of isopropanol and acetonitrile (2:1, v/v). For each run, aliquots (100 μl) of the crude extract were injected and separated on the column using the following gradient: 0%-50% solvent B over 5 min, followed by 50%-100% solvent B through 15 min at a flow rate of 1 mL/min. Elution was monitored using a UV detector at a wavelength of 220 nm. Fractions were collected every 20 s using a fraction collector (Fraction Collector II; Waters Cooperation). Active fractions from HPLC were pooled, air-dried and resuspended in water for a second round of HPLC purification. Purification was achieved using the same column and solvents but with an isocratic elution (35% solvent B over 22 min).
Mass spectrometric analysis
Molecular weights of the compounds were measured using matrix-assisted laser desorption/ionization, coupled with time-of-flight (MALDI-TOF) mass spectrometer (ultrafleXtreme; Bruker Daltonics Inc., Billerica, MA). Briefly, a sample of the purified antimicrobials was mixed with a matrix at a ratio of 1:5. The matrix was α-cyano-4-hydroxy cinnamic acid, which was prepared as a saturated solution in 50% acetonitrile with 0.1% TFA in water. The mixture was then spotted (1 μl) on the target plate and allowed to air dry. The instrument was operated in reflection-positive ion mode. The nitrogen laser source was operated at the minimum threshold level required to generate signal and minimize dissociation.
Peptide sequential analysis was performed using capillary liquid chromatography (LC), coupled with tandem mass spectrometer (MS/MS) (LTQ Orbitrap XL; Thermo Scientific, Waltham, MA), equipped with ion spray source (CaptiveSpray; Bruker Daltonics Billerica, MA) and operated in positive ion mode. For LC, an HPLC system (UltiMate 3000; Thermo Scientific) and a two-solvent mobile phase (A: water containing 50 mM acetic acid and B: acetonitrile) were used. Five microliters of each sample were first loaded onto the micro-precolumn cartridge (Thermo Scientific), and washed with 50 mM acetic acid. The peptides were eluted off the cartridge onto a C 18 column connected with the cartridge through a switching valve. A chromatographic C 18 column (0.2 × 150 mm, 5 μm particle size, 200 A pore size; Bruker Daltonics Inc.) was used for peptide separations. Peptides were eluted directly off the column into the mass spectrometer using a gradient of 2%-80% solvent B, over 45 min, with a flow rate of 2 μl/min. The total run time was 60 min. The MS/MS spectra were acquired with the spray source operated at a spray voltage of 2.2 KV and the capillary temperature was 175
• C. The collision-induced dissociation fragmentation energy was set to 35%.
Chemical synthesis and antimicrobial activity of linear paenipeptins A , B and C
Linear analogs corresponding to paenipeptins A, B and C were synthesized by the solid-phase peptide synthesis and purified by HPLC to homogeneity (>95% purity) through commercial custom peptide services (InnoPep, San Diego, CA, and Genscript Inc., Piscataway, NJ). These synthetic paenipeptin analogs were designated as paenipeptin A , B and C ( 
Hemolytic activities of linear paenipeptins A , B and C
Hemolytic activities of paenipeptin analogs were evaluated using defibrinated rabbit blood in a 96-well plate (Cochrane et al. 2014) . Briefly, rabbit blood (Hardy Diagnostics, Santa Maria, CA) was diluted with phosphate buffered saline (PBS) solution at a 1:19 ratio and the free hemoglobin was removed by centrifugation at 1000× g at 4
• C for 5 min; the process was repeated for three more times. Paenipeptin analogs at final concentrations of 32, 64 and 128 μg/mL were incubated with red blood cells at 37
• C for 30 min in a microtiter plate (NBS, Corning Inc.). Triton X-100 (0.1%), which lyses red blood cells, was used as a positive control. After incubation, samples were gently mixed by repeated pipetting. Aliquots (20 μl) of each mixture were dispensed in wells of a 96-well plate and mixed with 200 μl of PBS, followed by centrifugation at 2204× g for 10 min. The absorbance of the supernatant was measured at 415 nm using a Cell Imaging Multimode Reader (Cytation 3, BioTek; Winooski, VT) and percentage hemolysis of paenipeptin analogs was calculated relative to that caused by Triton X-100.
RESULTS
Purification of antimicrobial agents
Preliminary experiments indicated that Paenibacillus sp. OSY-N, when cultured in TSB for up to 3 days, did not produce antimicrobial agents. However, this new isolate produced strong antimicrobial agents when grown on solid medium, e.g. TSA. Liquid chromatography of antimicrobials, extracted from the cells, produced a fraction with the retention of 7.54 min from the isocratic elution, having activity against Listeria innocua and Escherichia coli.
Structure determination by mass spectrometry
MALDI-TOF and LC-MS/MS analyses showed that the active HPLC fraction contained a mixture of six analogs ( Fig. 1 and Table 1 
Cyclic paenipeptin C ([M+H]
+ , 1115.68 m/z), the new member of the permetin/pelgipeptin family, and its linear counterpart (paenipeptin C; [M+H] + , 1133.57 m/z) have the same peptide structure as paenipeptin B, but with a C 8 -, instead of C 7 -fatty acyl side chain ( Fig. 2 and Table 1 ). Paenipeptin C, in its cyclic or linear form, has not been reported before to the best of our knowledge.
Antimicrobial and hemolytic activity of the synthetic analogs, paenipeptin A , B and C
During separation by HPLC, members of this family of lipopeptides were co-eluted under a single fraction and the group collectively exhibited potent antimicrobial activity. Despite repeated effort, separation of individual paenipeptins from each other by liquid chromatography was experimentally challenging, presumably due to the close similarity of their structures. In the purified but co-eluted paenipeptins, the most abundant compound was paenipeptin B, a linear lipopeptide (Fig. 1) . This observation promoted us to target linear paenipeptins as potential alternatives to their cyclic counterparts. Therefore, three analogs of the new linear paenipeptins were produced by the solid-phase peptide synthesis technique and the products were designated as paenipeptins A , B and C . The chiral configuration of each amino acid residue in paenipeptin C was selected according to the amino acid configuration of permetin A (Takeuchi et al. 1979) . The MIC of the three compounds was determined against selected 19 bacterial strains (Table 2) . Gram-negative bacteria, generally, were more sensitive to the paenipeptins than were the Gram-positive bacteria. Paenipeptin C , with a C 8 -fatty acid chain, showed better activities than that of paenipeptins A and B , which carry a C 7 -fatty acid chain. The isoleucine residue at position 2 in paenipeptin B is replaced by a valine residue in paenipeptin A ; this substitution is presumed to cause a decrease in hydrophobicity in paenipeptin A . As a result, paenipeptin B showed stronger activity than paenipeptin A . The MIC of paenipeptin C ranged from 0.5-4 μg/mL for Gramnegative strains and 0.5-32 μg/mL for Gram-positive strains (Table 2). Moreover, when compared with the MIC of cyclic lipopeptide permetin A/pelgipeptin B (Takeuchi et al. 1979; Wu et al. 2010) , the synthetic linear analog, paenipeptin C , had better activity against Gram-negative bacteria. These results suggest that cyclization through the macrolatone ring is not essential for the antimicrobial activity of the lipopeptides in the permetin/pelgipeptin family. The variation in N-terminal fatty acyl chain and amino acid residue had substantial impact on paenipeptins' hemolytic activities. All three paenipeptin analogs showed very low hemolytic activity at 64 μg/mL. Paenipeptins A and B with a C 7 -fatty acid chain were not hemolytic at 128 μg/mL but paenipeptin C with a C 8 -fatty acid chain showed 25% hemolytic activity compared to the Triton X-100 control (Table 3) .
DISCUSSIONS
The antimicrobial agents of Paenibacillus sp. OSY-N were produced on agar medium, but were not detectable in the liquid form of the same medium. Other antimicrobial agents, such as the lipopeptide, paenibacterin (Guo et al. 2012 ) and the lantibiotic from Bifidobacterium longum DJO10A (Lee et al. 2011) , are also produced on the solid media only. Antimicrobial agents produced on the agar plates generally can be extracted by selected organic solvents, such as acetonitrile, isopropanol or acetone, depending on the properties of the target compounds.
Cyclic lipopeptide consist of a peptide in a ring structure with an N-terminal fatty acid chain. Prominent lipopeptides of clinical importance include daptomycin (Baltz, Miao and Wrigley 2005) , polymyxins (Velkov et al. 2010 ) and echinocandins (Cappelletty and Eiselstein-McKitrick 2007) . The permetin/pelgipeptin lipopeptides from the genera of Bacillus and Paenibacillus are broad-spectrum antimicrobial agents with potent activity against Gram-positive and Gram-negative bacteria (Takeuchi et al. 1979; Wu et al. 2010; Ding et al. 2011) . The lactone linkage (or ester bond) of cyclic lipopeptides can be removed by alkaline hydrolysis, resulting in the linearized lipopeptides. Hydrolysis is usually performed to facilitate the structure elucidation of lipopeptides prior to mass spectrometry analysis. In this study, three naturally occurring linear lipopeptides of the permetin/pelgipeptin family were isolated for the first time from Paenibacillus sp. OSY-N. Cyclic paenipeptin C, and its liner counterpart, possess a C 8 -fatty acyl chain; these lipopeptides were not reported previously in the permetin/pelgipeptin family (Takeuchi et al. 1979; Wu et al. 2010; Ding et al. 2011) . Most importantly, the synthetic linear analog, paenipeptin C , retained the potent antimicrobial activity expressed by the mixture. The overall hydrophobicity of the paenipeptin lipopeptides has a significant impact on their antibacterial and hemolytic activities. With the increase of the length of the fatty acyl chain from C 7 to C 8 or the substitution of valine to isoleucine at position 2 in the peptide, we observed an increase of antimicrobial activity which is accompanied by an elevation of hemolysis.
Synthesis of cyclic lipopeptides remains a challenge for solidphase peptide synthesis. Chemical synthesis of linear lipopeptides will allow for the easy access to more diverse lipopeptides. The findings of this study open the door for large-scale production of linear paenipeptins and their derivatives by chemical synthesis for animal study or clinical trials.
